{"id":58456,"date":"2023-11-22T10:02:00","date_gmt":"2023-11-22T09:02:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/"},"modified":"2023-11-22T10:02:00","modified_gmt":"2023-11-22T09:02:00","slug":"natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/","title":{"rendered":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK"},"content":{"rendered":"
\n

\n\u2022 The skincare firm Natura Biss\u00e9 is set to close 2023 with a revenue of 100 million euros and aims to double its presence in Europe over the next 3 years.<\/b><\/p>\n

\n\u2022 Arch Amenities Group will close the year with a revenue of 200 million dollars within their spa vertical and aims to become an authority in Europe in 2024 as a consulting and management group.<\/b><\/p>\n

BARCELONA, Spain & NEW YORK–(BUSINESS WIRE)–Natura Biss\u00e9 & Arch Amenities Group Europe have announced a formal collaboration to increase their collective presence in the luxury spa sector across the EU and the United Kingdom. The agreement fosters strategic and complementary growth opportunities for both brands, which will reference each other, capitalizing on the well-established reputation of the Natura Biss\u00e9 brand, its professional and retail skincare products and services and Arch Amenities Group\u2019s experience in managing and operating pre-eminent luxury wellness centers and spas.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nThe Spanish skincare firm, Natura Biss\u00e9, currently has a presence in more than 450 spa hotels around the world\u201435% of which are located in Europe\u2014and is set to close the year with a total revenue of 100 million euros. With its headquarters in Barcelona, 82% of the company\u2019s sales are recorded abroad, with the Unites States and China being its primary markets, followed by Spain. Over the next 3 years, Europe will become the company\u2019s strategic focus with the aim of doubling its multi-channel presence in this region.<\/p>\n

\nFor its part, Arch Amenities Group and its 3800 employees currently manage over 430 properties around the world. Private clubs, fitness centers, commercial and residential spaces and, of course, hotels place their trust in the Group\u2019s extensive experience. Among the hotel groups in their portfolio of clients are big names like Waldorf Astoria, Four Seasons and The Ritz-Carlton, who are also partners of Natura Biss\u00e9 across the world.<\/p>\n

\nNatura Biss\u00e9 has been part of Arch Amenities Group\u2019s Preferred Vendor Program since early 2023, connecting the Natura Biss\u00e9 product suite to a host of renowned U.S.-based spas and wellness spaces such as the Eden Roc Miami Beach Resort or the Waldorf Astoria Washington DC.<\/p>\n

\nToday this partnership adopts a new character as a \u201cnon-exclusive strategic agreement\u201d in Europe, at a time when the hospitality sector is seeing increased demand for elevated wellness experiences. Proof of this comes from data in a recent report from the Global Wellness Institute, which highlights consistent 12% annual growth in the wellbeing market since 2020 and forecasts a further 52% growth by 2027.<\/p>\n

\n\u201cThis strategic agreement represents a step-change in the way both leading brands address the changing needs of the European market and reinforces our collective commitment to offer unlimited innovation, inspiration as a pillar of growth and bespoke agile solutions. That is why I\u2019m convinced that our collaboration with Arch Amenities Group Europe will allow us to expand our presence in first-class spas and wellbeing centers,\u201d<\/i> says Ver\u00f3nica Fisas, CEO at Natura Biss\u00e9 Group.<\/p>\n

\n\u201cPartnering with Natura Biss\u00e9 in Europe to develop spas is an ideal fit for Arch as we grow our presence in Europe. As one of the most celebrated luxury skincare brands in the world, our strategic collaboration with Natura Biss\u00e9 allows us to extend our proven expertise in developing and managing luxury wellness spaces to bring guests an unparalleled experience powered by great products, outstanding hospitality and elevated service,\u201d<\/i> says Barry Goldstein, CEO at Arch Amenities Group.<\/p>\n

\nABOUT ARCH AMENITIES GROUP<\/b><\/p>\n

\nArch Amenities Group<\/a>, based in Rockville, Maryland, is a leading provider of hospitality management and consulting services for commercial and residential properties, hotels, spas and private clubs and recreation spaces worldwide. Arch provides daily management services as well as feasibility studies, planning and design consultancy as well as recruiting, pre-opening and sustaining strategy and support. Arch is a portfolio company of private equity firm CI Capital Partners<\/a>.<\/p>\n

\nABOUT NATURA BISS\u00c9<\/b><\/p>\n

\nNatura Biss\u00e9<\/a> is a globally renowned luxury skincare company. Founded in Barcelona in 1979, Natura Biss\u00e9 fuses pioneering technology with the most delicate human touch in order to listen and adapt to the differing needs of each and every client.<\/p>\n

\nThe constant pursuit of excellence has earned Natura Biss\u00e9 numerous awards, notably recognition for being the \u201cWorld\u2019s Best Spa Brand\u201d for four consecutive years (2018-2021).<\/p>\n

\nWith presence in 40 countries, Natura Biss\u00e9 continues to expand around the world throughout the most distinguished luxury retailers and best-in-class spas.<\/p>\n

\nIn 2008 the brand helped establish the Ricardo Fisas Natura Biss\u00e9 Foundation to contribute to the well-being of people in vulnerable situations. To support the Foundation\u2019s initiatives, Natura Biss\u00e9 has three fundraising lines of hotel toiletries.<\/p>\n

\nImages available here<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nPress Contact: <\/b>Ram\u00f3n Torn\u00e9 \/ A\u00efda Castells \u00b7 Telephone:<\/b> +34 932 172 217
\n
Email:<\/b> rtorne@llorenteycuenca.com<\/a> \/ acastells@llorenteycuenca.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u2022 The skincare firm Natura Biss\u00e9 is set to close 2023 with a revenue of 100 million euros and aims to double its presence in Europe over the next 3 years. \u2022 Arch Amenities Group will close the year with a revenue of 200 million dollars within their spa vertical and aims to become an … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58456","6":"format-standard","7":"category-industry"},"yoast_head":"\nNATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u2022 The skincare firm Natura Biss\u00e9 is set to close 2023 with a revenue of 100 million euros and aims to double its presence in Europe over the next 3 years. \u2022 Arch Amenities Group will close the year with a revenue of 200 million dollars within their spa vertical and aims to become an ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-22T09:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK\",\"datePublished\":\"2023-11-22T09:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/\"},\"wordCount\":792,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231122952800\\\/en\\\/1950653\\\/21\\\/Barry_Goldstein_-_Arch_Amenities_Group.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/\",\"name\":\"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231122952800\\\/en\\\/1950653\\\/21\\\/Barry_Goldstein_-_Arch_Amenities_Group.jpg\",\"datePublished\":\"2023-11-22T09:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231122952800\\\/en\\\/1950653\\\/21\\\/Barry_Goldstein_-_Arch_Amenities_Group.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231122952800\\\/en\\\/1950653\\\/21\\\/Barry_Goldstein_-_Arch_Amenities_Group.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/","og_locale":"en_US","og_type":"article","og_title":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend","og_description":"\u2022 The skincare firm Natura Biss\u00e9 is set to close 2023 with a revenue of 100 million euros and aims to double its presence in Europe over the next 3 years. \u2022 Arch Amenities Group will close the year with a revenue of 200 million dollars within their spa vertical and aims to become an ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/","og_site_name":"Pharma Trend","article_published_time":"2023-11-22T09:02:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK","datePublished":"2023-11-22T09:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/"},"wordCount":792,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/","url":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/","name":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg","datePublished":"2023-11-22T09:02:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231122952800\/en\/1950653\/21\/Barry_Goldstein_-_Arch_Amenities_Group.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/natura-bisse-and-arch-amenities-group-europe-announce-a-strategic-collaboration-in-the-eu-market-and-the-uk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NATURA BISS\u00c9 and ARCH AMENITIES GROUP EUROPE Announce a Strategic Collaboration in the EU Market and the UK"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58456"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58456\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}